Measurement of Intracellular Nitric Oxide with a Quantitative Mass Spectrometry Probe Approach
Measurement of Intracellular Nitric Oxide with a Quantitative Mass Spectrometry Probe Approach
复制标题
用定量质谱探针法测量细胞内一氧化氮
DOI:
10.1021/acs.analchem.1c01259
复制
发表时间:
2021
影响因子:
7.4
通讯作者:
Gui-Zhong Xin
中科院分区:
文献类型:
--
作者:
Zhu-Jun Zhong;Zhong-Ping Yao;Zi-Qi Shi;Yang-Dan Liu;Li-Fang Liu;Gui-Zhong Xin
Nitric oxide (NO) is a molecule of physiological importance, and the function of NO depends on its concentration in biological systems, particularly in cells. Concentration-based analysis of intracellular NO can provide insight into its precise role in health and disease. However, current methods for detecting intracellular NO are still inadequate for quantitative analysis. In this study, we report a quantitative mass spectrometry probe approach to measure NO levels in cells. The probe, Amlodipine (AML), comprises a Hantzsch ester group that reacts with NO to form a pyridine, Dehydro Amlodipine (DAM). Quantification of DAM by ultraperformance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) allows specific measurement of intracellular NO levels. Notably, the AML/NO reaction proceeds rapidly (within 1 s), which is favorable for NO detection considering its large diffusivity and short half-life. Meanwhile, studies under simulated physiological conditions revealed that the AML response to NO is proportional and selective. The presented UPLC–MS/MS method showed high sensitivity (LLOQ = 0.24 nM) and low matrix interference (less than 15%) in DAM quantification. Furthermore, the mass spectrometry probe approach was demonstrated by enabling the measurement of endogenous and exogenous NO in cells. Hence, the quantitative UPLC–MS/MS method developed using AML as a probe is expected to be a new method for intracellular NO analysis.